Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase 3 10Phase 2/3 5Phase NA 4Phase 1/2 4Phase 4 2Phase 1 1

Status

Unknown 5Completed 3Terminated 2Recruiting 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Other neoplasm 2Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

TP53 1Multiple Myeloma 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myeloid, Acute 1Allogeneic Hematopoietic Stem Cell Transplantation 1

Interventions

Cisplatin 20Docetaxel 19Capecitabine 19Oxaliplatin 14Drug Therapy 14Cyclophosphamide 14Paclitaxel 13Fluorouracil 12Radiotherapy 11apatinib 9Gemcitabine 9Doxorubicin 9Decitabine 9Methotrexate 8Epirubicin 8Carboplatin 8sintilimab 6Etoposide 6camrelizumab 5anlotinib 5XELOX 5Sorafenib 5Radiation 5Pemetrexed 5Neoadjuvant Therapy 5Leucovorin 5Idarubicin 5Dexamethasone 5Cytarabine 5Busulfan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2/3 × Unknown × Busulfan × Clear all
NCT03530085 2020-12-22

Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT

Nanfang Hospital, Southern Medical University

Phase 2/3 Unknown
60 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03385096 2020-02-25

Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT

Nanfang Hospital, Southern Medical University

Phase 2/3 Unknown
122 enrolled
Plasma cell

Multiple Myeloma

NCT04123392 2019-10-10

Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT

Nanfang Hospital, Southern Medical University

Phase 2/3 Unknown
196 enrolled
Other neoplasm

TP53

NCT04098653 2019-09-23

Decitabine + BUCY vs BUCY Conditioning Regimen for Myeloid Tumors Undergoing Allo-HSCT

Nanfang Hospital, Southern Medical University

Phase 2/3 Unknown
196 enrolled
Other neoplasm

Allogeneic Hematopoietic Stem Cell Transplantation

NCT03229616 2017-10-12

BUCY+VP-16 vs BUCY Conditioning Regimen for DLBCL Undergoing Auto-HSCT

Nanfang Hospital, Southern Medical University

Phase 2/3 Unknown
122 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡